Based on recent findings in experimental animals, there is growing concern that MDMA and fenfluramine may be toxic to serotonin (5HT) neurons in the human brain. Despite this concern. human use of MDMA and fenfluramine continues. MDMA is used as a recreational drug, and some mental health specialists claim it has psychotherapeutic utility. Fenfluramine is an anorectic agent. It is used in the treatment of obesity, and also in the therapy of autistic children. Recently, N-methylation has been found to selectively attenuate the 5HT neurotoxic activity of methamphetamine, a congener of MDMA and fenfluramine. The goal of this research is to test the hypothesis that N-methylation will also attenuate the 5HT neurotoxic activity of MDMA and fenfluramine without eliminating their behavioral activity. To this end, N-methylated analogs of MDMA and fenfluramine have been synthesized. Their identity and purity has been confirmed and pilot neurotoxicity studies have been carried out. These show that N-methylated analogs of MDMA and fenfluramine have reduced 5HT neurotoxic activity. In addition, preliminary behavioral studies suggest that these analogs retain pharmacological activity. The present studies will systematically characterize and compare the neurotoxic, behavioral, and biochemical properties of N-methylated analogs of MDMA and fenfluramine. Neurotoxicologically, combined chemical and anatomical methods will be used to assess the neurotoxic potential of these analogs. Behaviorally, their anorectic, reinforcing, psychomotor stimulant and discriminative stimulus properties will be investigated, and compared to that of their parent compounds. Biochemically,the metabolic fate of the various N-methylated analogs and their parent compounds will be characterized in vitro in an effort to identify important toxification and detoxification mechanisms. As part of this effort, metabolic intermediates will be synthesized, and their neurotoxic and behavioral profiles will also be investigated. The long-term objectives of this research are: 1) to develop non-toxic analogs of MDMA and fenfluramine which retain clinically useful pharmacological activity and 2) to use such analogs to delineate the mechanism of neurotoxic action of MDMA and related compounds.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA006275-02
Application #
3212904
Study Section
Special Emphasis Panel (SRCD (16))
Project Start
1991-08-15
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1993-07-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Szabo, Zsolt; McCann, Una D; Wilson, Alan A et al. (2002) Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43:678-92
Varga, Jozsef; Szabo, Zsolt (2002) Modified regression model for the Logan plot. J Cereb Blood Flow Metab 22:240-4
Winsauer, Peter J; McCann, Una D; Yuan, J et al. (2002) Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration. Psychopharmacology (Berl) 159:388-96
Kim, S; Westphalen, R; Callahan, B et al. (2000) Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293:625-33
Callahan, B T; Yuan, J; Ricaurte, G A (2000) Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine. Synapse 38:471-6
Ricaurte, G A; McCann, U D; Szabo, Z et al. (2000) Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'). Toxicol Lett 112-113:143-6
Ricaurte, G A; Yuan, J; McCann, U D (2000) (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:10-May
Hatzidimitriou, G; McCann, U D; Ricaurte, G A (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-107
McCann, U D; Yuan, J; Ricaurte, G A (1998) Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain. Synapse 30:239-46
Bolla, K I; McCann, U D; Ricaurte, G A (1998) Memory impairment in abstinent MDMA (""Ecstasy"") users. Neurology 51:1532-7

Showing the most recent 10 out of 29 publications